Skip to content
Shameless Cloning

Search Shameless Cloning

Search superinvestors, stocks, insiders and members of Congress

Q2 2026 13F · SEC CIK 1015083

Emerald Advisers, LLC

Institutional asset managerFiled 2026-08-05 for Q2 2026. Open the filing ↗ · All SEC filings ↗

Reported 13F value
$4.2B
Reported positions
237
Top holdings a year, 3 yrs
+43.2%
Assets under management
$3.3B

Emerald Advisers, LLC is an institutional asset manager that reported 237 positions worth $4.2B in its Q2 2026 13F, filed 2026-08-05. Its largest holdings were Travere Therapeutics Inc (TVTX, 2.1%), Cardinal Infrastructure Group (CDNL, 1.9%), Mercury Systems Inc (MRCY, 1.8%). A portfolio copying its top holdings returned 43.2% a year over the last 3 years, against 20.4% for the S&P 500.

Emerald Advisers, LLC holdings largest 50 of 237 positions.

Weights are shares of the filer's total reported 13F value, compared with Q1 2026. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.

Emerald Advisers, LLC 13F holdings
Stock% of 13F valueShare changeReported value
TVTXTravere Therapeutics Inc2.1%+2.8%$90.9M
CDNLCardinal Infrastructure Group1.9%—$79.9M
MRCYMercury Systems Inc1.8%+7.3%$78.1M
AIRAar Corp1.8%+17.1%$74.6M
VSECVse Corp1.7%+2.7%$73.8M
KLICKulicke & Soffa Inds Inc1.7%-3.1%$73.8M
AGXArgan, Inc.1.7%-6.3%$71.3M
CECOCeco Environmental Corp1.6%+40.9%$66.9M
CORTCorcept Therapeutics Inc Com1.5%—$65.1M
LIVNLivanova PLC1.5%+17.4%$64.7M
SMTCSemtech Corp1.5%-14.0%$63.6M
IDCCInterdigital Inc1.5%+114.8%$63.3M
ESEEsco Technologies Inc1.5%+10.5%$62.9M
ACLSAxcelis Technologies Inc1.5%—$62.6M
PDFSPdf Solutions Inc1.5%+2.7%$62.6M
PLXSPlexus Corp1.5%+24.7%$62.5M
COHUCohu Inc1.5%—$62.4M
COGTCogent Biosciences Inc1.5%+1.0%$62.0M
ALGTAllegiant Travel Co1.3%+40.6%$55.9M
LGNLegence Corp1.3%—$55.7M
MIRMMirum Pharmaceuticals Inc1.3%+17.9%$54.8M
GHGuardant Health Inc1.3%-56.8%$54.6M
MODModine Mfg Co1.3%-46.4%$54.1M
AXAxos Financial Inc1.2%+8.0%$52.2M
SOISolaris Energy Infras Inc1.2%+7.7%$51.5M
LASRNlight Inc1.2%-1.3%$51.3M
SYRESpyre Therapeutics1.2%-7.5%$50.4M
UMBFUmb Finl Corp1.2%+29.3%$49.4M
BOOTBoot Barn Holdings Inc1.2%+44.0%$49.3M
RSIRush Street Interactive Inc1.1%+4.2%$48.8M
SXTSensient Technologies Corp1.1%—$48.7M
BLLNBilliontoone Inc1.1%—$45.1M
AGYSAgilysys Inc1.1%—$44.7M
ATROAstronics Corp1.0%+14.4%$41.8M
TTMITTM Technologies, Inc.1.0%-70.5%$41.4M
COMPCompass Inc1.0%—$40.6M
FRPTFreshpet Inc0.9%+40.2%$39.8M
LTHLife Time Group Holdings Inc0.9%—$39.7M
FAFirst Advantage Corp0.9%—$39.5M
TEXTerex Corp New0.9%—$39.5M
CYTKCytokinetics Inc0.9%—$39.0M
IPGPIpg Photonics Corp0.9%+7.1%$38.3M
EYENational Vision Holdings0.9%+33.5%$38.1M
DIODDiodes Incorporated0.9%—$37.8M
HRIHerc Holdings Inc0.9%—$37.4M
SYNASynaptics Inc0.9%—$37.1M
MXLMaxlinear Inc0.8%—$35.9M
MANEVeradermics Inc0.8%—$35.5M
VRNSVaronis Systems Inc0.8%—$35.3M
PVLAPalvella Therapeutics Inc0.8%—$35.1M

What Emerald Advisers, LLC bought and sold in Q2 2026, against Q1 2026.

New positions

Q1 2026's filing was too long to tell new positions apart.

Reduced

Share counts compared with the Q1 2026 13F; a split also changes share counts. The latest filing lists more than 50 positions, so a position that left the top 50 may still be held.

How the holdings did against the S&P 500.

1 year
+61.5% /yr
S&P 500 +20.1%
3 years
+43.2% /yr
S&P 500 +20.4%
5 years
+15.9% /yr
S&P 500 +11.6%

A portfolio of the filer's 20 largest 13F positions, weighted by value and rebuilt each quarter on the day the filing became public. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.

Reported 13F value by quarter.

13F value by quarter
Quarter13F valuePositions
Q2 2026$4.2B237
Q1 2026$3.2B248
Q4 2025$3.2B246
Q3 2025$3.1B256
Q2 2025$2.7B248
Q1 2025$2.2B243
Q4 2024$2.6B254
Q3 2024$2.6B248
Q2 2024$2.4B247
Q1 2024$2.5B243
Q4 2023$2.3B242
Q3 2023$2.1B232

Questions about Emerald Advisers, LLC's portfolio

What stocks does Emerald Advisers, LLC own?

Emerald Advisers, LLC's latest 13F, for Q2 2026 and filed Aug 5, 2026, lists 237 positions worth $4.2B. The largest are Travere Therapeutics Inc (TVTX) at 2.1%, Cardinal Infrastructure Group (CDNL) at 1.9%, Mercury Systems Inc (MRCY) at 1.8%, Aar Corp (AIR) at 1.8% and Vse Corp (VSEC) at 1.7%.

What did Emerald Advisers, LLC buy last quarter?

In Q2 2026, Emerald Advisers, LLC added Interdigital Inc (IDCC) (+114.8% shares), Boot Barn Holdings Inc (BOOT) (+44.0% shares) and Ceco Environmental Corp (CECO) (+40.9% shares), compared with its Q1 2026 filing.

What did Emerald Advisers, LLC sell last quarter?

In Q2 2026, Emerald Advisers, LLC cut from its top 50 Bloom Energy Corp (BE), cut from its top 50 Kratos Defense & Sec Solutio (KTOS), cut from its top 50 Fabrinet (FN), cut from its top 50 Credo Technology Group Holdi (CRDO), cut from its top 50 Rambus Inc Del (RMBS), TTM Technologies, Inc. (TTMI) (-70.5% shares), Guardant Health Inc (GH) (-56.8% shares) and Modine Mfg Co (MOD) (-46.4% shares), compared with its Q1 2026 filing.

How has Emerald Advisers, LLC's portfolio performed?

A portfolio copying Emerald Advisers, LLC's 20 largest 13F holdings each quarter, from the day each filing was public, returned +43.2% a year over the last 3 years, against +20.4% for the S&P 500. Over 1 year: +61.5% against +20.1%. Over 5 years: +15.9% a year against +11.6%.

When is Emerald Advisers, LLC's next 13F filing due?

13F filings are due 45 days after each quarter ends. Emerald Advisers, LLC's filing for the quarter ending Sep 30, 2026 is due by Nov 14, 2026; this page updates the day after it is published.

How much money does Emerald Advisers, LLC manage?

Emerald Advisers, LLC reported $3.3B of regulatory assets under management on its latest SEC Form ADV. Its 13F, which covers only US-listed stocks and options, totals $4.2B.